NIH-funded research R01 grant

Understanding how HLA genetics affects kidney transplant success

Official title: HLA Immunogenetics and kidney allograft outcomes

Funded at University of Pennsylvania · NIH-10991029 · Data updated 2026-11-12

This study is looking at how certain genetic differences in proteins called HLA alloantigens can affect the success of kidney transplants, helping doctors understand how to match donors and recipients better for improved transplant outcomes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startNovember 21, 2022
Project endOctober 31, 2027
Funding year2025
Award (this year)$728,342
NIH project number5R01AI173095-03
Project IDNIH-10991029 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals undergoing kidney transplantation who have specific HLA genetic profiles.

Less likely to help

Patients who are not candidates for kidney transplantation or those with incompatible HLA types may not benefit from this research.

What this research studies

This research investigates the role of HLA alloantigens in kidney transplantation, focusing on how genetic variations in these proteins can influence the success of kidney grafts. By analyzing the genetic makeup of both donors and recipients, the study aims to identify specific amino acid variations that may lead to immune responses against transplanted kidneys. The research will utilize advanced molecular typing techniques to gather comprehensive data on HLA mismatches and their correlation with transplant outcomes, particularly in diverse patient populations. This approach seeks to improve organ allocation strategies and enhance long-term graft survival.

Why it matters

Potential benefit: If successful, this research could lead to improved kidney transplant outcomes and longer-lasting grafts for patients.

How similar studies have gone: Previous studies have shown promising results in understanding HLA mismatches and their impact on transplant outcomes, indicating that this research builds on established findings.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Kamoun, Malek — University of Pennsylvania
  • Study coordinator: Kamoun, Malek

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.